CMG Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 0.00001 million compared to KRW 0.00002 million a year ago. Net income was KRW 2,695.78 million compared to KRW 189.47 million a year ago.

Basic earnings per share from continuing operations was KRW 19 compared to KRW 1 a year ago. Basic earnings per share was KRW 19 compared to KRW 1 a year ago.